From August 18th 2026, GtoPdb will require users to register to use the website. Please see our blog post for more information.

elranatamab   Click here for help

GtoPdb Ligand ID: 12889

Synonyms: elranatamab-bcmm | Elrexfio® | PF-06863135 | PF06863135
Approved drug Immunopharmacology Ligand
elranatamab is an approved drug (FDA & EMA (2023))
Compound class: Antibody
Comment: Elranatamab (PF-06863135) is a TNFRSF17(BCMA)/CD3e bispecific monoclonal antibody. It was designed to promote T cell-mediated anti-myeloma activity by simultaneously engaging these two protein targets on B and T cells [1,3].
Immunopharmacology Comments
A B cell maturation antigen (TNFRSF17(BCMA)-targeting bispecific T cell (CD3e) engaging monoclonal for the treatment of multiple myeloma.